This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Kyungpook National University Industry-Academic Cooperation Foundation, Novmetapharma Co., Ltd.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 368 
1 out of 4 Years Active: 2017-2026
Title: Keun Gyu Park: Innovator in Pharmaceutical Composition
Introduction
Keun Gyu Park is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at enhancing anticancer effects and treating renal fibrosis. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
One of his latest patents is titled "Use of composition for enhancing anticancer effect, comprising ERRy inhibitor as active ingredient." This invention focuses on a pharmaceutical composition designed to inhibit the resistance of liver cancer to sorafenib, utilizing an Estrogen-related receptor γ (ERRγ) inhibitor as the active ingredient. This composition shows promise for treating sorafenib-resistant advanced liver cancer.
Another significant patent is "Composition for preventing or treating renal fibrosis comprising dimethylfumarate as active ingredient." This invention relates to a composition that employs dimethylfumarate (DMF) to prevent or treat renal fibrosis. The DMF activates Nrf2 to inhibit TGF-β/Smad signaling, demonstrating an excellent effect in reducing renal fibrosis.
Career Highlights
Keun Gyu Park has worked with reputable organizations, including the Kyungpook National University Industry-Academic Cooperation Foundation and Novmetapharma Co., Ltd. His experience in these institutions has contributed to his innovative research and development in pharmaceuticals.
Collaborations
He has collaborated with notable colleagues, including In Kyu Lee and Han Jong Kim. Their joint efforts have further advanced the research and applications of his inventions.
Conclusion
Keun Gyu Park's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to addressing significant health challenges, particularly in cancer and renal diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile